CIK: 1314596 - Address: C/o Syndax Pharmaceuticals, Inc., 35 Gatehouse Drive, Building D, Floor 3, Waltham, MA 02451
36 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
P%ret1136-2-156713312652
P%wins67505050505053
S%ret1111-2-3-317264413
S%wins91555527333349

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/7/22 16:05
10/6/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKatkin KeithMADM.d2458.20030999%32D
10/7/22 16:05
10/6/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKatkin KeithMADS.d-77425.900-30-4832D
10/4/22 17:49
9/30/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKatkin KeithMADM.dm338.11041532D
10/4/22 17:49
9/30/22
SNDXSyndax Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsKatkin KeithMADS.dm-10325.060-4-1132D
2/21/20 18:42
2/19/20
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsKatkin KeithCADOPEO;CEO,M.d6953.860180915200D
12/11/19 17:01
12/9/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsKatkin KeithCADOPEO;CEO,M.d4633.8601200D
12/11/19 17:01
12/9/19
UROVUrovant Sciences Ltd.D0HealthDrugPharmaceutical PreparationsKatkin KeithCADOPEO;CEO,S.d-1,53412.780-120-1000D
12/18/14 08:52
12/15/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.dm-4,70516.950-278-23914D
12/18/14 08:52
12/15/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOM.d3141.61019527914D
10/24/14 20:34
10/24/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-32411.760-28-4733D
8/1/14 20:44
8/1/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-515.260-10-1760D
5/30/14 20:00
5/28/14
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.d-2,2155.010-442-37750D
12/20/13 17:24
12/18/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-792.670-30-6446D
11/5/13 20:00
11/1/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-184.140-4-1475D
8/2/13 19:58
8/2/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-754.840-16-3480D
5/17/13 20:02
5/15/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.d-8163.260-250-34495D
5/17/13 20:02
5/15/13
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOM.d1700.7893021577495D
12/19/12 16:48
6/25/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOM.ad1380.7259019056530D
12/5/12 16:39
12/3/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-462.550-18-13119D
6/27/12 17:00
6/25/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-6653.500-190-58138D
3/7/12 09:00
3/6/12
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOP262.614103328D31-23-111-6-11-8-57
12/6/11 17:01
12/2/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-412.374-17-8191D37-33-34-6-13-1244-1-11-1810
11/18/11 20:01
11/16/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOM.dm1530.70082218208D40-42-41-6-16-15-7-1-8-20-2614
11/18/11 20:01
11/16/11
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.dm-5652.592-218-51208D40-42-41-6-16-15-7-1-8-20-2614
12/3/10 20:55
12/2/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOM.d1040.530019195999%208D999122664041-16-7-5-3-34-1112-40
12/3/10 20:55
12/2/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.d-7974.0819-195-48208D999122664041-16-7-5-3-34-1112-40
11/2/10 21:55
11/1/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-1145.7025-20-12146D999162554568416677010-6-8-7-31
9/2/10 16:30
8/31/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.m-2922.843-103-38167D202534810-11-63-6-7-8124422-3
5/4/10 20:19
4/30/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.m-3343.157-106-28271D169246686647352-1-12-185-2137
4/9/10 18:56
4/8/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-303.013-10-3377D190498405762401921-3-9-240-426
3/31/10 15:28
3/29/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-782.601-30-7387D134363152225111311-21444134162
1/11/10 20:37
1/4/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.am-671.921-35-8419D552691-1863-2-116-116685124
1/5/10 19:50
1/4/10
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS.m-671.921-35-8418D56369-11198530213555114
12/16/09 21:43
12/15/09
AVNRAvanir Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOS-681.821-37-7505D917421-13-2-1-4-2-21101555104
2/25/09 15:34
2/24/09
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsKatkin KeithCADOP,CEOP70.43940153593-2-110150332316
5/25/06 20:44
5/25/06
AVNRAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsKatkin KeithCAOSVP of SP228.9943New3127-30-17-66-64

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact